Admission to Trading and PDMR Shareholdings

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN.

MENHADEN CAPITAL PLC

Admission to trading and PDMR shareholdings

31 July 2015: Further to its announcement on 29 July 2015 that it has raised £80 million in its initial public offering, Menhaden Capital PLC (the “Company") is pleased to announce that at 8.00am today its ordinary shares were admitted to listing on the premium segment of the Official List and to trading on (i) the Main Market of the London Stock Exchange and (ii) the Social Stock Exchange Segment of the ICAP Securities & Derivatives Exchange Main Board ("Admission"). The Company's ordinary shares will trade under the TIDM: MHN.

The total number of ordinary shares in the Company in issue immediately following Admission is 80 million, each with equal voting rights. This total voting rights figure can be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in the Company under the Disclosure and Transparency Rules of the UK Financial Conduct Authority.

On Admission, the beneficial interests of Directors in the issued share capital of the Company are as follows:

Director	Number of ordinary shares	% of issued share capital
Sir Ian Cheshire	25,000	0.03%
Emma Howard Boyd	8,000	0.01%
Duncan Budge	10,000	0.01%

For further details contact:

Numis Securities (Investors)                       020 7260 1000

James Glass (Sales)

Maurice Franks (PCFM)

David Benda (Corporate Broking & Advisory)

Freddie Naylor-Leyland (Corporate Broking & Advisory)

MHP Communications (Media)                   020 3128 8100

Mark Lunn

James Morgan